Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Diagnosis of Cervical Cancer and Pre-Cancerous Lesions by Artificial Intelligence: A Systematic Review Publisher



Allahqoli L1 ; Lagana AS2 ; Mazidimoradi A3 ; Salehiniya H4 ; Gunther V5 ; Chiantera V2 ; Karimi Goghari S6 ; Ghiasvand MM7 ; Rahmani A8 ; Momenimovahed Z9 ; Alkatout I5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Midwifery Department, Ministry of Health and Medical Education, Tehran, 1467664961, Iran
  2. 2. Unit of Gynecologic Oncology, ARNAS “Civico-Di Cristina-Benfratelli�, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, 90127, Italy
  3. 3. Neyriz Public Health Clinic, Shiraz University of Medical Sciences, Shiraz, 7134814336, Iran
  4. 4. Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, 9717853577, Iran
  5. 5. University Hospitals Schleswig-Holstein, Kiel School of Gynaecological Endoscopy, Campus Kiel, Arnold-Heller-Str. 3, Haus 24, Kiel, 24105, Germany
  6. 6. School of Industrial and Systems Engineering, Tarbiat Modares University (TMU), Tehran, 1411713114, Iran
  7. 7. Department of Computer Engineering, Amirkabir University of Technology (AUT), Tehran, 1591634311, Iran
  8. 8. Nursing and Midwifery Care Research Centre, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, 141973317, Iran
  9. 9. Reproductive Health Department, Qom University of Medical Sciences, Qom, 3716993456, Iran

Source: Diagnostics Published:2022


Abstract

Objective: The likelihood of timely treatment for cervical cancer increases with timely detection of abnormal cervical cells. Automated methods of detecting abnormal cervical cells were established because manual identification requires skilled pathologists and is time consuming and prone to error. The purpose of this systematic review is to evaluate the diagnostic performance of artificial intelligence (AI) technologies for the prediction, screening, and diagnosis of cervical cancer and pre-cancerous lesions. Materials and Methods: Comprehensive searches were performed on three databases: Medline, Web of Science Core Collection (Indexes = SCI-EXPANDED, SSCI, A & HCI Timespan) and Scopus to find papers published until July 2022. Articles that applied any AI technique for the prediction, screening, and diagnosis of cervical cancer were included in the review. No time restriction was applied. Articles were searched, screened, incorporated, and analyzed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Results: The primary search yielded 2538 articles. After screening and evaluation of eligibility, 117 studies were incorporated in the review. AI techniques were found to play a significant role in screening systems for pre-cancerous and cancerous cervical lesions. The accuracy of the algorithms in predicting cervical cancer varied from 70% to 100%. AI techniques make a distinction between cancerous and normal Pap smears with 80–100% accuracy. AI is expected to serve as a practical tool for doctors in making accurate clinical diagnoses. The reported sensitivity and specificity of AI in colposcopy for the detection of CIN2+ were 71.9–98.22% and 51.8–96.2%, respectively. Conclusion: The present review highlights the acceptable performance of AI systems in the prediction, screening, or detection of cervical cancer and pre-cancerous lesions, especially when faced with a paucity of specialized centers or medical resources. In combination with human evaluation, AI could serve as a helpful tool in the interpretation of cervical smears or images. © 2022 by the authors.
Other Related Docs
35. The Epidemiology of Brain and Spinal Cord Tumors, Advances in Experimental Medicine and Biology (2023)
41. Direct and Indirect Medical Costs of Bladder Cancer in Iran, Cost Effectiveness and Resource Allocation (2023)
43. Anti-Cd20 Antibody Treatment for B-Cell Malignancies, Resistance to Anti-CD20 Antibodies and approaches for their Reversal: Volume 2 (2023)